Shopping Cart

Close

No products in the cart.

LeadR Profile


Maurizio Muscaritoli
Sapienza University of Rome
Italy

SLR Nutrition ScienceLeadR Reputation 100%

Favorite Settings

Follow this Expert

Health Specialties

Main specialty  Nutrition
Full career - Last 3 years

Main Topics

Publications and Clinical Trials


Publications - Clinical Trials

Education

Academic Background

Source: ORCID

Organization

all information about organizations

Source: Pubmed

Sapienza University of Rome

Awards and Honors

Source: ORCID

Academic Societies

Source: ORCID

Publications Synthesis

Source: Pubmed

Number : 270

Citations

Citations: 9 553 1st author: 37 Last author: 77 Unique author: 3

Main journals

Clin Nutr 32
Intern Emerg Med 14
Nutrition 14
J Cachexia Sarcopenia Muscle 12
Front Nutr 11

Best Journals

Lancet Oncol 2

Breakdown by type

Historic per year



Main pathologies and trends

Publications List

Quick search selection

Source: Pubmed Source: OpenAlex
Title Journal CIT SLR Year
Guidance for assessment of the inflammation etiologic criterion for the GLIM diagnosis of malnutrition: A modified Delphi approach. JPEN J Parenter Enteral Nutr
38221842
0 3.4 2024
Assessment of lipolysis biomarkers in adipose tissue of patients with gastrointestinal cancer. Cancer Metab
38167536
0 0 2024
Small non-coding RNA profiling in patients with gastrointestinal cancer. J Cachexia Sarcopenia Muscle
37743227
1 8.9 2023
GLIM-diagnosed malnutrition predicts mortality and risk of hospitalization in systemic sclerosis: A retrospective study. Eur J Intern Med
37482470
0 8 2023
Omega-3 fatty acids in parenteral nutrition - A systematic review with network meta-analysis on clinical outcomes. Clin Nutr
36878111
1 6.3 2023
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022. Clin Nutr
36947988
6 6.3 2023
Guidance for assessment of the inflammation etiologic criterion for the GLIM diagnosis of malnutrition: A modified Delphi approach. Clin Nutr
38238189
0 6.3 2023
Disease-related malnutrition with inflammation and cachexia. Clin Nutr
37302879
3 6.3 2023
Overcoming barriers to timely recognition and treatment of cancer cachexia: Sharing Progress in Cancer Care Task Force Position Paper and Call to Action. Crit Rev Oncol Hematol
36931616
1 6.2 2023
Fatigue in Patients on Chronic Hemodialysis: The Role of Indoleamine 2,3-Dioxygenase (IDO) Activity, Interleukin-6, and Muscularity. Nutrients
36839234
0 5.9 2023
A Low Daily Intake of Simple Sugars in the Diet Is Associated with Improved Liver Function in Cirrhotic Liver Transplant Candidates. Nutrients
37049416
1 5.9 2023
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study. Cancers (Basel)
37370816
3 5.2 2023
Standardization of Body Composition Status in Patients with Advanced Urothelial Tumors: The Role of a CT-Based AI-Powered Software for the Assessment of Sarcopenia and Patient Outcome Correlation. Cancers (Basel)
37296930
0 5.2 2023
Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO). Cancers (Basel)
36672329
2 5.2 2023
Prevention and treatment of catheter-related venous thrombosis in long-term parenteral nutrition: A SINuC position statement. Front Nutr
36814508
1 5 2023
Early impairment of food intake in patients newly diagnosed with cancer. Front Nutr
36687669
2 5 2023
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both. Intern Emerg Med
36773107
1 4.6 2023
Fever and dyspnea after anti-Covid-19 vaccination: a challenging diagnosis. Intern Emerg Med
37566358
1 4.6 2023
A 36-year-old man, body builder presenting with unexpected severe anemia. Intern Emerg Med
36929351
0 4.6 2023
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register. Intern Emerg Med
37535294
0 4.6 2023
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register. Intern Emerg Med
36964858
0 4.6 2023
CHADS-VASc score as a predictor of clinical outcomes in hospitalized patients with and without chronic kidney disease. J Nephrol
37938543
0 3.4 2023
COVID-19 and kidney: role of SARS-CoV-2 infection in the induction of renal damage. Eur Rev Med Pharmacol Sci
37667963
0 3.3 2023
Metabolic and histomorphological changes of adipose tissue in cachexia. Curr Opin Clin Nutr Metab Care
36942899
1 3.1 2023
Changes in renal microcirculation in patients with nephrotic and nephritic syndrome: The role of resistive index. Microvasc Res
38072161
0 3.1 2023
Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study. Int Urol Nephrol
37043156
0 2 2023
Resistant Hypertension and Related Outcomes in a Cohort of Patients with Cardiorenal Multimorbidity Hospitalized in an Internal Medicine Ward. High Blood Press Cardiovasc Prev
38010537
0 0 2023
Evaluation of Anorexia in Cancer and Its Association with Autonomic Nervous System Activity Assessed by Heart Rate Variability. Nutrients
38068794
0 0 2023
Changes of gene expression in peripheral blood mononuclear cells of lung cancer patients with or without anorexia. Clin Nutr
36473427
0 6.3 2022
COVID-19: Lessons on malnutrition, nutritional care and public health from the ESPEN-WHO Europe call for papers. Clin Nutr
36075815
1 6.3 2022
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of malnutrition. Clin Nutr
35450768
29 6.3 2022
Nutrition education in medical schools (NEMS) project: Promoting clinical nutrition in medical schools - Perspectives from different actors. Clin Nutr
36473759
0 6.3 2022
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients. Eur J Clin Invest
36453932
0 5.5 2022
Evaluation of Browning Markers in Subcutaneous Adipose Tissue of Newly Diagnosed Gastrointestinal Cancer Patients with and without Cachexia. Cancers (Basel)
35454855
4 5.2 2022
Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors. Front Nutr
35464004
4 5 2022
Editorial: Muscle mass and function in COVID-19. Front Nutr
36466420
0 5 2022
Phase angle, nutritional status, and mortality in systemic sclerosis: An exploratory pilot study. Nutrition
36577164
0 4.4 2022
Angiogenic factors as prognostic markers in neuroendocrine neoplasms. Endocrine
35088292
4 3.7 2022
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition diagnosis of malnutrition. JPEN J Parenter Enteral Nutr
35437785
11 3.4 2022
Commentary on "Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition". JPEN J Parenter Enteral Nutr
35650681
1 3.4 2022
Assessment of renal microcirculation in biopsy-proven tubulointerstitial nephritis in patients with and without glomerular disease: the role of resistive index. Microvasc Res
35588888
0 3.1 2022
Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients. Microvasc Res
35346718
3 3.1 2022
Nephroangiosclerosis not related to hypertension: A matter to resolve in the era of precision medicine. J Hum Hypertens
36577802
1 2.7 2022
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry. Age Ageing
32926127
1 12.782 2021
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis. J Cachexia Sarcopenia Muscle
34448539
18 12.063 2021
Role of metabolic changes of adiposity in cancer. Trends Endocrinol Metab
34509360
1 10.586 2021
Histomorphological and inflammatory changes of white adipose tissue in gastrointestinal cancer patients with and without cachexia. J Cachexia Sarcopenia Muscle
34939367
4 8.9 2021
The relevance of nutritional and metabolic derangements in COVID-19 patients. Eur J Intern Med
34952767
0 8 2021
The link between nutritional status and outcomes in COVID-19 patients in ICU: Is obesity or sarcopenia the real problem? Eur J Intern Med
34246503
9 7.749 2021
Nutrition education in medical schools (NEMS) project: Joining ESPEN and university point of view. Clin Nutr
33933741
1 7.643 2021
ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr
33946039
145 7.643 2021
Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study. Nutrients
33925672
7 6.706 2021
The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study. Nutrients
34371806
5 6.706 2021
Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review. Front Nutr
34409063
2 6.59 2021
The Impact of Nutrients on Mental Health and Well-Being: Insights From the Literature. Front Nutr
33763446
21 6.59 2021
A Clinical Perspective of Low Carbohydrate Ketogenic Diets: A Narrative Review. Front Nutr
34322508
13 6.59 2021
Goals in Nutrition Science 2020-2025. Front Nutr
33665201
9 6.576 2021
Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs. Int J Mol Sci
34445710
3 6.208 2021
Awareness of Cancer-Related Malnutrition and Its Management: Analysis of the Results From a Survey Conducted Among Medical Oncologists. Front Oncol
34055649
11 5.738 2021
Corrigendum: Metabolic Reprogramming Promotes Myogenesis During Aging. Front Physiol
34054583
2 4.755 2021
A patient with severe anemia and body weight loss: unveiling what was behind. Intern Emerg Med
33590409
0 4.6 2021
Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients. Drugs Aging
34860347
2 4.271 2021
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry. Acta Diabetol
33890176
4 4.087 2021
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register). Endocrine
33433894
2 3.925 2021
A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection. Eur Rev Med Pharmacol Sci
34661250
2 3.784 2021
Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis. Crit Care
33143750
10 9.097 2020
Safety and tolerability of a novel oral nutritional supplement in healthy volunteers. Clin Nutr
32675020
1 7.643 2020
Nutrition education in medical schools (NEMS). An ESPEN position paper. Clin Nutr
32690431
1 7.324 2020
Association between Growth Differentiation Factor-15 (GDF-15) Serum Levels, Anorexia and Low Muscle Mass among Cancer Patients. Cancers (Basel)
33396237
10 6.639 2020
Pain and Frailty in Hospitalized Older Adults. Pain Ther
33058084
10 5.725 2020
What Are the Risk Factors for Malnutrition in Older-Aged Institutionalized Adults? Nutrients
32961917
9 5.717 2020
The Facts about Food after Cancer Diagnosis: A Systematic Review of Prospective Cohort Studies. Nutrients
32764484
8 5.717 2020
Both ghrelin deletion and unacylated ghrelin overexpression preserve muscles in aging mice. Aging (Albany NY)
32712599
10 5.682 2020
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry. Intern Emerg Med
32720248
11 5.472 2020
Body composition and microvascular damage in systemic sclerosis patients. J Endocrinol Invest
32683616
0 5.467 2020
Association Between Metabolic and Hormonal Derangements and Professional Exposure to Urban Pollution in a High Intensity Traffic Area. Front Endocrinol (Lausanne)
32849295
2 4.91 2020
Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters. Toxins (Basel)
32526852
4 4.546 2020
Lipid Use in Hospitalized Adults Requiring Parenteral Nutrition. JPEN J Parenter Enteral Nutr
32049396
8 4.016 2020
Pharmacoeconomics of Parenteral Nutrition with ω-3 Fatty Acids in Hospitalized Adults. JPEN J Parenter Enteral Nutr
32049391
1 4.016 2020
Summary of Proceedings and Expert Consensus Statements From the International Summit "Lipids in Parenteral Nutrition". JPEN J Parenter Enteral Nutr
32049392
11 4.016 2020
Left Ventricular Mass Index as Potential Surrogate of Muscularity in Patients With Systemic Sclerosis Without Cardiovascular Disease. JPEN J Parenter Enteral Nutr
32794588
0 4.016 2020
Assessing Malnutrition in Systemic Sclerosis With Global Leadership Initiative on Malnutrition and European Society of Clinical Nutrition and Metabolism Criteria. JPEN J Parenter Enteral Nutr
32384169
3 3.896 2020
Cost-Effectiveness of Parenteral Nutrition Containing ω-3 Fatty Acids in Hospitalized Adult Patients From 5 European Countries and the US. JPEN J Parenter Enteral Nutr
32713007
1 3.896 2020
Phase angle could be a marker of microvascular damage in systemic sclerosis. Nutrition
32179402
3 3.58 2020
Autonomic dysfunction in kidney diseases. Eur Rev Med Pharmacol Sci
32894552
9 3.507 2020
Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients. Clin Rheumatol
32447602
1 2.98 2020
Correction to: Phase angle in systemic sclerosis: a marker for pulmonary function and disease severity. Clin Rheumatol
32314174
0 2.98 2020
Phase angle in systemic sclerosis: a marker for pulmonary function and disease severity. Clin Rheumatol
32170485
0 2.98 2020
Targeted Medical Nutrition in Pre-Cachectic Patients with Non-Small-Cell Lung Cancer: A Subgroup Analysis. Nutr Cancer
32519909
0 2.816 2020
Cardiovascular risk and quality of life in autosomal dominant polycystic kidney disease patients in therapy with tolvaptan: A pilot study. Curr Vasc Pharmacol
32957887
2 2.719 2020
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study. Integr Cancer Ther
31370717
7 2.379 2020
Nutritional and metabolic derangements in Mediterranean cancer patients and survivors: the ECPC 2016 survey. J Cachexia Sarcopenia Muscle
30953399
11 9.802 2019
GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle
30920778
193 9.802 2019
Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa. J Cachexia Sarcopenia Muscle
31307125
14 9.802 2019
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle
30920776
59 9.802 2019
Sarcopenia: A Time for Action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle
31523937
174 9.802 2019
From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patients. Ther Adv Med Oncol
31762796
25 6.951 2019
Nutrition education in medical schools (NEMS). An ESPEN position paper. Clin Nutr
30772092
8 6.36 2019
nNOS/GSNOR interaction contributes to skeletal muscle differentiation and homeostasis. Cell Death Dis
31043586
4 6.304 2019
Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials. Expert Opin Investig Drugs
31347405
6 5.081 2019
DHA Oral Supplementation Modulates Serum Epoxydocosapentaenoic Acid (EDP) Levels in Breast Cancer Patients. Oxid Med Cell Longev
30949290
2 5.076 2019
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function. J Mol Biol
31150737
40 4.76 2019
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids. J Am Med Dir Assoc
30852169
2 4.367 2019
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. Eur J Intern Med
31405773
1 4.329 2019
ω-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta-Analysis and Trial Sequential Analysis. JPEN J Parenter Enteral Nutr
31250474
22 4.016 2019
Patient access to oral nutritional supplements: Which policies count? Nutrition
31539815
1 3.58 2019
α-lipoic acid in patients with autosomal dominant polycystic kidney disease. Nutrition
31790890
7 3.58 2019
Metabolic Reprogramming Promotes Myogenesis During Aging. Front Physiol
31354530
14 3.408 2019
Longitudinal Physical Activity Change During Hemodialysis and Its Association With Body Composition and Plasma BAIBA Levels. Front Physiol
31293456
6 3.408 2019
Safety and Tolerability of Targeted Medical Nutrition for Cachexia in Non-Small-Cell Lung Cancer: A Randomized, Double-Blind, Controlled Pilot Trial. Nutr Cancer
31290697
6 2.9 2019
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register. Intern Emerg Med
31444740
0 2.322 2019
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study. Med Princ Pract
30889568
1 1.295 2019
GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr
30181091
437 6.36 2018
Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines. Oncotarget
29876019
13 5.168 2018
Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion. Int J Mol Sci
30400622
16 4.183 2018
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation. Br J Clin Pharmacol
29745441
15 3.867 2018
Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy. Nutrition
30875540
28 3.769 2018
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards. Eur J Intern Med
29657108
3 3.66 2018
GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community. JPEN J Parenter Enteral Nutr
30175461
104 2.853 2018
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register. Intern Emerg Med
30171585
16 2.335 2018
Prognostic Factors of Renal Involvement in Systemic Sclerosis. Kidney Blood Press Res
29763902
6 2.123 2018
Nutrition support for treating cancer-associated weight loss: an update. Curr Opin Support Palliat Care
30382948
5 1.916 2018
Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial. J Cachexia Sarcopenia Muscle
28891198
32 10.754 2017
ESPEN guideline clinical nutrition in neurology. Clin Nutr
29274834
80 6.402 2017
Cancer-induced muscle wasting: latest findings in prevention and treatment. Ther Adv Med Oncol
28529552
73 6.238 2017
Unifying diagnostic criteria for cachexia: An urgent need. Clin Nutr
28238466
5 5.496 2017
ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr
28689670
248 5.496 2017
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget
29108370
88 5.168 2017
Vitamin D and VDR in cancer cachexia and muscle regeneration. Oncotarget
28423519
16 5.168 2017
Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both? Oxid Med Cell Longev
28694914
28 4.936 2017
Anti-catabolic neurohormonal blockade to improve skeletal muscle during disease. Expert Opin Biol Ther
29019426
0 3.974 2017
Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients. Front Physiol
28804463
9 3.325 2017
Interference with Ca-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia. Front Physiol
28469577
11 3.325 2017
The role of vitamin D in cancer cachexia. Curr Opin Support Palliat Care
28922293
8 2.073 2017
The Domains of Human Nutrition: The Importance of Nutrition Education in Academia and Medical Schools. Front Nutr
28275609
5 0 2017
Corrigendum: Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function. Front Nutr
29018802
1 0 2017
Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function. Front Nutr
28367435
1 0 2017
Targeting cancer cachexia: we're on the way. Lancet Oncol
26906527
4 33.9 2016
Perspectives of health care professionals on cancer cachexia: results from three global surveys. Ann Oncol
28007753
21 11.855 2016
The Three Faces of Sarcopenia. J Am Med Dir Assoc
27161851
5 5.775 2016
Mini-Nutritional Assessment, Malnutrition Universal Screening Tool, and Nutrition Risk Screening Tool for the Nutritional Evaluation of Older Nursing Home Residents. J Am Med Dir Assoc
27528452
24 5.775 2016
Effectiveness and efficacy of nutritional therapy: A systematic review following Cochrane methodology. Clin Nutr
27448948
23 5.496 2016
ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr
27642056
467 5.496 2016
Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. Clin Nutr
27686693
27 5.496 2016
ESPEN guidelines on nutrition in cancer patients. Clin Nutr
27637832
604 5.496 2016
Autophagy is induced in the skeletal muscle of cachectic cancer patients. Sci Rep
27459917
72 4.259 2016
Foods and their components promoting gastrointestinal cancer. Curr Opin Clin Nutr Metab Care
27389082
1 4.023 2016
Novel therapeutic options for cachexia and sarcopenia. Expert Opin Biol Ther
27382931
16 3.684 2016
The metabolite beta-aminoisobutyric acid and physical inactivity among hemodialysis patients. Nutrition
28063504
8 3.487 2016
The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast Cancer. Int J Mol Sci
27058527
11 3.226 2016
Interactions between dietary supplements in hospitalized patients. Intern Emerg Med
27544221
0 2.34 2016
Anorexia assessment in patients with cancer: a crucial issue to improve the outcome. J Clin Oncol
25753439
1 24.008 2015
Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting. J Cachexia Sarcopenia Muscle
27239411
31 9.697 2015
Request for regulatory guidance for cancer cachexia intervention trials. J Cachexia Sarcopenia Muscle
26675232
57 9.697 2015
Carnitine for the treatment of cachexia: Lights and shadows. Int J Cardiol
26163913
0 6.189 2015
Economy matters to fight against malnutrition: Results from a multicenter survey. Clin Nutr
26586302
4 5.496 2015
Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr
25799486
348 4.548 2015
Effect of personalized dietary intervention on nutritional, metabolic and vascular indices in patients with chronic kidney disease. Eur Rev Med Pharmacol Sci
26439028
8 1.778 2015
Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J
25234804
97 10.569 2014
Left ventricular mass correlates with lean body mass in patients with disease-associated wasting. J Cachexia Sarcopenia Muscle
24898355
8 9.697 2014
Evidence-based recommendations for addressing malnutrition in health care: an updated strategy from the feedM.E. Global Study Group. J Am Med Dir Assoc
24997720
27 5.775 2014
Cachexia: a preventable comorbidity of cancer. A T.A.R.G.E.T. approach. Crit Rev Oncol Hematol
25468676
25 4.971 2014
The conundrum of pre-cachexia existence. Clin Nutr
25453398
0 4.548 2014
Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr
24785098
124 4.548 2014
Ghrelin: from discovery to cancer cachexia therapy. Curr Opin Clin Nutr Metab Care
24905862
15 4.023 2014
Cancer cachexia: towards integrated therapeutic interventions. Expert Opin Biol Ther
25017968
2 3.684 2014
Cortisol and the muscle-bone axis. Osteoporos Int
25001985
1 3.591 2014
The role for dietary omega-3 fatty acids supplementation in older adults. Nutrients
25285409
32 3.55 2014
Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients. Eur J Clin Nutr
25469466
6 3.057 2014
Towards improved awareness and earlier diagnosis of early onset colorectal neoplasms. Intern Emerg Med
24986080
1 2.34 2014
Sarcopenia and its therapeutic strategies in ICU. Minerva Anestesiol
24430009
0 2.134 2014
Malnutrition: the hidden killer in healthcare systems. BMJ
23485639
4 20.785 2013
Interventions to promote energy balance and cancer survivorship: priorities for research and care. Cancer
23695926
9 6.072 2013
Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model. Clin Nutr
24345520
8 4.548 2013
MuRF-1 and p-GSK3β expression in muscle atrophy of cirrhosis. Liver Int
23432902
17 4.116 2013
Nutritional care in a nursing home in Italy. PLoS One
23405217
11 4.034 2013
The hunger hormone ghrelin in cachexia. Expert Opin Biol Ther
23289712
4 3.684 2013
Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials. Amino Acids
24057808
28 3.173 2013
CaMKII activity is reduced in skeletal muscle during sepsis. J Cell Biochem
23238742
2 3.085 2013
Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patients. Muscle Nerve
23861230
11 2.605 2013
Muscle depletion and the prediction of chemotherapy toxicity. Intern Emerg Med
23754272
1 2.34 2013
Sarcopenia in critically ill patients: the new pandemia. Minerva Anestesiol
23370125
5 2.272 2013
Timing of antioxidant supplementation is critical in improving anorexia in an experimental model of cancer. Int J Food Sci Nutr
23301688
2 1.444 2013
n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. Crit Care
23036226
41 5.358 2012
Parenteral nutrition in advanced cancer patients. Crit Rev Oncol Hematol
22365185
4 4.971 2012
Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks. Br J Nutr
23153477
18 3.706 2012
Effect of intensive nutritional counseling and support on clinical outcomes of hemodialysis patients. Nutrition
22554958
10 3.18 2012
Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutrition
22677356
10 3.18 2012
β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy. Biochem Biophys Res Commun
22705301
20 2.466 2012
Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia? Intern Emerg Med
22773188
22 2.34 2012
Cancer cachexia: from molecular mechanisms to patient's care. Crit Rev Oncog
22831162
10 1.429 2012
Effectiveness and cost-effectiveness of supplemental glutamine dipeptide in total parenteral nutrition therapy for critically ill patients: a discrete event simulation model based on Italian data. Int J Technol Assess Health Care
22617735
3 0.912 2012
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol
21296615
1701 33.9 2011
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc
21640657
337 5.775 2011
Changes in myostatin signaling in non-weight-losing cancer patients. Ann Surg Oncol
21519918
30 4.041 2011
Metabolic and clinical effects of the supplementation of a functional mixture of amino acids in cerebral hemorrhage. Neurocrit Care
20972646
3 2.752 2011
Insulin signaling and tight glucose control: a genetic link? Nat Rev Endocrinol
20213885
1 18.318 2010
Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? Int J Cancer
20039316
53 6.513 2010
Consensus on cachexia definitions. J Am Med Dir Assoc
20439040
44 5.775 2010
Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc
20627179
177 5.775 2010
Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr
20060626
503 4.548 2010
Fluid intake and nutritional risk in non-critically ill patients at hospital referral. Br J Nutr
20447327
3 3.706 2010
β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. Int J Oncol
21184031
31 3.079 2010
Nutritional care routines in Italy: results from the PIMAI (Project: Iatrogenic MAlnutrition in Italy) study. Eur J Clin Nutr
20502467
5 3.057 2010
The "parallel pathway": a novel nutritional and metabolic approach to cancer patients. Intern Emerg Med
20596799
30 2.34 2010
Are antioxidants useful for treating skeletal muscle atrophy? Free Radic Biol Med
19591922
14 5.606 2009
ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr
19477052
116 4.548 2009
Glutamine as indispensable nutrient in oncology: experimental and clinical evidence. Eur J Nutr
19936817
28 4.37 2009
Malnutrition and wasting in renal disease. Curr Opin Clin Nutr Metab Care
19474712
22 4.023 2009
Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload. J Neurol
19240952
3 3.389 2009
Inflammation and nutritional risk: a feature to consider in planned oncologic surgery. World J Surg
19649756
1 2.673 2009
Modifications of fasting glucose values as first sign of resistance in chronic myeloid leukemia chronic phase patients during imatinib treatment. Leuk Res
20018374
0 2.501 2009
Cachexia: a new definition. Clin Nutr
18718696
776 4.548 2008
Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest
18578694
67 2.714 2008
Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib. Leuk Res
18321570
21 2.501 2008
New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'. Asia Pac J Clin Nutr
18296386
4 1.816 2008
Is des-acyl ghrelin contributing to uremic anorexia? Am J Clin Nutr
17991673
0 6.926 2007
Statins, coenzyme Q10, and cachexia: what's the link? Am J Cardiol
17950821
1 3.398 2007
Free tryptophan/large neutral amino acids ratios in blood plasma do not predict cerebral spinal fluid tryptophan concentrations in interleukin-1-induced anorexia. Pharmacol Biochem Behav
18045669
2 2.748 2007
Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol
17556836
22 2.658 2007
Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib. Leuk Res
17382388
19 2.501 2007
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clin Nutr
16697500
120 4.548 2006
Antimyopathic effects of carnitine and nicotine. Curr Opin Clin Nutr Metab Care
16778574
8 4.023 2006
Skeletal muscle apoptosis is not increased in gastric cancer patients with mild-moderate weight loss. Int J Biochem Cell Biol
16697691
3 3.505 2006
IGF-1 is downregulated in experimental cancer cachexia. Am J Physiol Regul Integr Comp Physiol
16614058
72 2.982 2006
Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib. Haematologica
16266912
8 7.702 2005
Malnutrition in hemodialysis patients: what therapy? Am J Kidney Dis
16129199
19 7.623 2005
Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia: a Cancer and Leukemia Group B study. Cancer
15578655
2 6.072 2005
Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer
16314085
62 6.029 2005
ESPEN guidelines on artificial enteral nutrition--percutaneous endoscopic gastrostomy (PEG). Clin Nutr
16261664
130 4.548 2005
Does leptin contribute to uraemic cachexia? Nephrol Dial Transplant
16352621
0 4.47 2005
Branched-chain amino acids: the best compromise to achieve anabolism? Curr Opin Clin Nutr Metab Care
15930966
20 4.023 2005
Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. Int J Oncol
15870883
10 3.079 2005
Switch from bicarbonate hemodialysis to hemodiafiltration with online regeneration of the ultrafiltrate (HFR): effects on nutritional status, microinflammation, and beta-microglobulin. Artif Organs
15725229
1 2.403 2005
Variables associated with reduced dietary intake in hemodialysis patients. J Ren Nutr
15827898
26 2.318 2005
Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself. Nat Clin Pract Oncol
16264909
95 0 2005
Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment. J Clin Oncol
15542819
35 24.008 2004
Therapy of muscle wasting in cancer: what is the future? Curr Opin Clin Nutr Metab Care
15192450
9 4.023 2004
Effects of simvastatin administration in an experimental model of cancer cachexia. Nutrition
14624942
6 2.061 2004
Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract
15292683
14 0 2004
Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol
12526946
30 9.566 2003
Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg
12616123
56 8.98 2003
Muscle ubiquitin m-rNA levels in patients with end-stage renal disease on maintenance hemodialysis. J Nephrol
12455723
4 2.153 2003
Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C. J Nephrol
12832744
4 2.153 2003
Tumor-induced changes in host metabolism: a possible role for free tryptophan as a marker of neoplastic disease. Adv Exp Med Biol
15206751
7 1.937 2003
Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr
11815308
27 6.926 2002
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. Cytokine
12200106
20 3.488 2002
Idiopathic AL amyloidosis and biclonal paraproteinemia: a case report and review of the literature. Amyloid
11676298
1 3.373 2001
Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regul Integr Comp Physiol
11294777
35 2.982 2001
Impaired nutritional status in common variable immunodeficiency patients correlates with reduced levels of serum IgA and of circulating CD4+ T lymphocytes. Eur J Clin Invest
11422405
7 2.714 2001
Albumin synthesis is diminished in men consuming a predominantly vegetarian diet. J Nutr
10702580
7 4.145 2000
VMN hypothalamic dopamine and serotonin in anorectic septic rats. Shock
10718377
3 3.113 2000
Serum tumour necrosis factor-alpha levels in cancer patients are discontinuous and correlate with weight loss. Eur J Clin Invest
11122326
9 2.714 2000
[Pathogenetic and therapeutic aspects of secondary anorexia]. Ann Ital Med Int
11059060
0 0 2000
Plasma amino acid concentrations in patients with acute myelogenous leukemia. Nutrition
10198913
7 3.42 1999
Peripherally injected IL-1 induces anorexia and increases brain tryptophan concentrations. Adv Exp Med Biol
10721046
5 1.937 1999
Effect of cisplatin and paclitaxel on plasma free tryptophan levels. An in vitro study. Adv Exp Med Biol
10721065
0 1.937 1999
Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. Transplantation
9753341
10 3.678 1998
Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity. Eur J Cancer
9135511
3 6.029 1997
[Energy metabolism in cancer patients]. Minerva Gastroenterol Dietol
16501445
0 0 1997
Biochemical indices may not accurately reflect changes in nutritional status after allogeneic bone marrow transplantation. Nutrition
8748194
4 3.42 1996
Cancer anorexia: new pathogenic and therapeutic insights. Nutrition
8850221
1 3.42 1996
Tumor-induced changes in host metabolism: a possible marker of neoplastic disease. Nutrition
8748231
6 3.42 1996
Mechanism of early tumor anorexia. J Surg Res
8598675
3 2.187 1996
Tryptophan and secondary anorexia. Adv Exp Med Biol
8906321
1 1.937 1996
Serotoninergic block in the ventromedial nucleus of hypothalamus improves food intake in anorectic tumor bearing rats. Adv Exp Med Biol
8906322
1 1.937 1996
Plasma amino acid imbalance in patients with lung and breast cancer. Anticancer Res
7763031
36 1.937 1995
Comparative effects of arginine and other amino acid deprivation on in vitro expression of lymphocyte activation markers. Clin Nutr
16843363
0 4.548 1994
Densitometry-based equations for estimating body composition in Fischer rats. Nutrition
8286884
2 3.42 1994
Cytokines, tryptophan and anorexia in cancer patients before and after surgical tumor ablation. Anticancer Res
8067720
5 1.937 1994

Clinical Trials 4 Source:  ClinicalTrials

Synthesis

Principal Investigator: 1

By phase:

N/A 4

By status:

Completed 2
Recruiting 1
Withdrawn 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Nutritional and Metabolic Diseases 2

Cohort/Consortium Investigators 4

Drugs and Sponsors Source: ClinicalTrials

All Clinical Trials information

Clinical Trials Breakdown information Source: ClinicalTrials

Breakdown by Phase

Breakdown by Status

Breakdown by Mono/Multi Centric

Percentage of internationnal

Clinical Trials Timeline Source: ClinicalTrials

Studies Phases and Years

Clinical Trials List Source: ClinicalTrials

Quick search selection

NCTID - Title Phase Status Year

NCT04318366

COVID 19 Patients Characterization Biobank Treatment Response and Outcome Predictor
N/A Recruiting 2020

NCT02515032

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia
N/A Completed 2015

NCT02442908

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia
N/A Completed 2015

NCT02154230

Sulphate bicarbonate calcium Water Body Weight and Gut Microbiota
N/A Withdrawn 2013

LeadR Networks Source: Pubmed Source: ClinicalTrials

Main global connection map



Nb Contacts:
Country Contact count
Italy 733
United States 53
Germany 31
Spain 28
United Kingdom 26
France 25
Switzerland 22
Brazil 17
Netherlands 15
Sweden 15
Belgium 14
Canada 10
Croatia 7
Denmark 7
Australia 5
Argentina 4
Greece 4
Israel 4
Norway 3
Portugal 3
Turkey 3
Hungary 2
Japan 2
Finland 1
India 1
Latvia 1
New Zealand 1
Poland 1
Qatar 1
Slovakia 1
Sri Lanka 1

LeadR Networks Source: Pubmed Source: ClinicalTrials

Graph connection

LeadR Networks Source: Pubmed Source: ClinicalTrials

Connection list

Name Organization Country Linked
Molfino Alessio Sapienza University of Rome Italy 98
Rossi Fanelli Filippo University of Applied Sciences and Arts of Southern Switzerland Switzerland 81
Laviano Alessandro Sapienza University of Rome Italy 36
Costelli Paola University of Turin Italy 30
Amabile Maria Ida Sapienza University of Rome Italy 25
Gigante Antonietta Sapienza University of Rome Italy 23
Biolo Gianni University of Trieste Italy 20
Imbimbo Giovanni Sapienza University of Rome Italy 20
Nobili Alessandro Mario Negri Institute for Pharmacological Research Italy 16
Rosato Edoardo Sapienza University of Rome Italy 16
Zanoli Luca Policlinico Universitario di Catania Italy 15
Perticone Francesco Magna Graecia University Italy 15
Peyvandi Flora Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Italy 15
Bossola Maurizio Agostino Gemelli University Polyclinic Italy 15
Squizzato Alessandro University of Insubria Italy 15
Castellino Pietro University of Catania Italy 15
Zanetti Michela University of Trieste Italy 15
Bianconi Vanessa University of Perugia Italy 15
Ardoino Ilaria Mario Negri Institute for Pharmacological Research Italy 15
Suppressa Patrizia Polytechnic University of Bari Italy 15
Monzani Valter Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Italy 15
Sabbà Carlo University of Bari Aldo Moro Italy 15
Manfredini Roberto University of Ferrara Italy 15
Succurro Elena Magna Graecia University Italy 14
Cipollone Francesco University of Chieti-Pescara Italy 14